Solution-phase parallel synthesis of substituted benzimidazoles

Journal of Combinatorial Chemistry

Volumn 4, Issue 4, 2002, Pages 320-328

  Raju, B ^a,b   Nguyen, Noel ^a   Holland, George W ^a  

^a TEXAS BIOTECHNOLOGY CORPORATION   (United States)

^b Versicor Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE;

EID: 0039486054     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc000098d     Document Type: Article

References (41)

1. (a) Gallop, M. A.; Barret, R. W.; Dower, W. J.; Fodor, S. P. A.; Gordon, E. M. J. Med. Chem. 1994, 37, 1385.
2. (b) Gordon, E. M.; Barret, R. W.: Dower, W. J.; Fodor, S. P. A.; Gallop, M. A. J. Med. Chem. 1994, 37, 1233.
3. (c) Balkenhohl, F.; Bussche-Hunnefeld, C.; Lanskt, A.; Zechel, C. Angew. Chem., Int. Ed. Engl. 1996, 335, 2288.
4. (d) Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. C. Tetrahedron 1996, 52, 4527.
5. (e) Thompson, L.; Ellman, J. A. Chem. Rev. 1996, 96, 555.
6. (f) Dewitt, S. H.; Czarnik, A. W. Acc. Chem. Res. 1996, 29, 114.
7. (g) Armstrong, R. W.; Combus, A. P.; Tempest, P. A.; Brown, D.; Keating, T. A. Acc. Chem. Res. 1996, 29, 1123.
8. (h) Ellman, J. A. Acc. Chem. Res. 1996, 29, 132.
9. (i) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Acc. Chem. Res. 1996, 29, 144.
10. (a) Cheng, S.; Comer, D. D.; Williams, J. P.; Myers, P. L.; Boger, D. L. J. Am. Chem. Soc. 1996, 118, 2567.
11. (b) Boger, D. L.; Chai, W. Tetrahedron 1998, 54, 3955.
12. (c) An, H.; Wang, T.; Mohan, V.; Griffey, R. H.; Dan Cook, P. Tetrahedron 1998, 54, 3999.
13. (d) Xie, Y. F.; Whitten, J. P.; Chen, T. Y.; Liu, Z.; McCarthy, J. R. Tetrahedron 1998, 54, 4077.
14. Johnson, C. R.; Zhang, B.; Fantauzzi, P.; Hocker, M.; Yager, K. M. Tetrahedron 1998, 54, 4097.
15. (a) Studer, A.; Hadida, S.; Ferritto, R.; Kim, S.-Y.; Jeger, P.; Wipf, P.; Curran, D. P. Science 1997, 275, 823.
16. (b) Studer, A.; Curran, D. P. Tetrahedron 1997, 53, 6681.
17. (a) Flynn, D. L.; Crich, J. Z.; Devaraj, R. V.; Hockerman, S. L.; Parlow, J. J.; South, M. S.; Woodara, S. J. Am. Chem. Soc. 1997, 119, 4874.
18. (b) Parlow, J. J.; Flynn, D. L. Tetrahedron 1998, 54, 4013.
19. (c) Siegel, M. G.; Hahn, P. J.; Dressman, B. A.; Grunwell, J. R.; Kaldor, S. W. Tetrahedron Lett. 1997, 38, 3357.
20. (d) Gayo, L. M.; Suto, M. J. Tetrahedron Lett. 1997, 38, 513.
21. (e) Ley, S. V.; Baxendale, I. R.; Bream, R. N.; Jackson, P. S.; Leach, A. G.; Longbottom, D. A.; Nesi, M.; Scott, J. S.; Storer, R. I.; Taylor, S. J. J. Chem. Soc., Perkin Trans. 1 2000, 3815.
22. (a) Kobayashi, S.; Nagayama, S. J. Am. Chem. Soc. 1996, 118, 8977.
23. (b) Jang, S. B. Tetrahedron Lett. 1997, 38, 1793.
24. (a) Booth, R. J.; Hodges, J. C. J. Am. Chem. Soc. 1997, 119, 4882.
25. (b) Creswell, M. W.; Bolton, G. L.; Hodges, J. C.; Meppen, M. Tetrahedron 1998, 54, 3983.
26. Raju, B.; Kassir, J. M.; Kogan, T. P. Bioorg. Med. Chem. Lett. 1998, 8, 3043.
27. (a) Phillips, G. B.; Wei, G. P. Tetrahedron Lett. 1996, 37, 4887.
28. (b) Wei, G. P.; Phillips, G. B. Tetrahedron Lett. 1998, 39, 179.
29. (c) Lee, J.; Gauthier, D.; Rivero, R. Tetrahedron Lett. 1998, 39, 201.
30. (d) Blettner, C. G.; Koning, W. A.; Ruhter, G.; Stenzel, W.; Schotten, T. Synlett. 1999, 3, 309.
31. (e) Yeh, C.; Sun, C. Tetrahedron Lett. 1999, 40, 7247.
32. (a) Cereda, E.; Turconi, M.; Ezhaya, A.; Bellora, E.; Brambilla, A.; Pagani, F.; Donetti, A. Eur. J. Med. Chem. 1987, 22, 527.
33. (b) Kugishima, H.; Horie, T.; Imafuku. K. J. Heterocycl. Chem. 1994, 31, 1557.
34. (c) Salluja, S.; Zou, R.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1996, 39, 881.
35. (d) Zarrinmayeh, H.; Zimmerman, D. M.; Cantrell, B. E.; Schober, D. A.; Bruns, R. F.; Gackenheimer, S. L.; Ornstein, P. L.; Hipskind, P. A.; Britton, T. C.; Gehlert, D. R. Bioorg. Med. Chem. Lett. 1999, 9, 647.
36. (e) Nair, M. D.; Nagarajan, K. Prog. Drug Res. 1980, 215, 321.
37. 1H NMR and IR spectra.
38. Advanced Organic Chemistry: Reactions, Mechanism and Structure, 4th ed.; March, J., Ed.; John Wiley and Sons: New York, 1992; p 1216.
39. 18 reverse-phase column (50 mm × 4.6 mm) eluting with a water/acetonitrile mixture containing 0.1% TFA from 20% to 100% acetonitrile (linear gradient) over 10 min. The purities of the intermediates and final products are based on HPLC and NMR spectroscopy.
40. (a) Xu, W.; Mohan, R.; Morrissey, M. M. Tetrahedron Lett. 1997, 38, 7337.
41. (b) Xu, W.; Mohan, R.; Morrissey, M. M. Bioorg. Med. Chem. Lett. 1998, 8, 1039.